EcoDrugPlus

Interleukin-6-Like

Ensembl ID : ENSAPOG00000006672
Gene Symbol: LOC110957018
2 Cross references
162 Possible Orthologues:

Inward Rectifier Potassium Channel 2-Like

Ensembl ID : ENSAPOG00000023250
Gene Symbol: LOC110959480
3 Cross references
202 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSAPOG00000022757
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial

Ensembl ID : ENSAPOG00000008457
Gene Symbol: LOC110949362
3 Cross references
196 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial-Like

Ensembl ID : ENSAPOG00000021462
Gene Symbol: LOC110954820
3 Cross references
204 Possible Orthologues:

Isotocin Receptor-Like

Ensembl ID : ENSAPOG00000005271
Gene Symbol: LOC110949912
3 Cross references
193 Possible Orthologues:

Jeltraxin-Like

Ensembl ID : ENSAPOG00000004534
Gene Symbol: LOC110952960
2 Cross references
385 Possible Orthologues:

Kappa-Type Opioid Receptor-Like

Ensembl ID : ENSAPOG00000022366
Gene Symbol: LOC110969704
3 Cross references
200 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSAPOG00000004671
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSAPOG00000021018
Gene Symbol: KDR
3 Cross references
198 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSAPOG00000012443
Gene Symbol: KIF11
3 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSAPOG00000018778
Gene Symbol: KIF5B
4 Cross references
245 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).